The role of the gut microbiome in nicotine withdrawal and dependence
Nicotine & Tobacco Research · 2026
DOI: 10.1093/ntr/ntag057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine & Tobacco Research, 2026. Verfasst von Eda Koseli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond VA 23298, United States. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Gastrointestinal Microbiome, Nicotine, Tobacco Use Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDA NIH HHS, NIH-NCI Cancer Center Support.
Abstract (Originalsprache)
Introduction
Smoking is considered a global pandemic, with more than 1.3 billion people being active smokers. Increasing evidence suggests that nicotine exposure can lead to changes in the gut microbiome, increases in permeability, and impaired mucosal immune responses in the gastrointestinal tract. However, the literature on behavioral aspects of nicotine-microbiome interaction, such as dependence and withdrawal, is limited. In this study, we used homologous fecal material transplants (FMT) to modify the gut microbiome and its impact on the intensity of nicotine withdrawal in mice.
Methods
We used osmotic minipumps (MPs) as an application of chronic nicotine for 15 days and orally gavaged FMT 2x a day to the mice. We assessed the nicotine withdrawal by measuring the number of somatic signs and anxiety-like behaviors at 24 h and 1 week after the mini pump removal. Fecal samples were also collected points to identify the gut microbiome changes.
Results
Fecal transplants reduced the number of somatic signs and anxiety-like behaviors in nicotine-treated mice up to a week after the removal of MPs. The shotgun metagenomic results of the fecal samples from 24 h after MP removal time point show altered gut microbiome with a significant shift in the species composition between the nicotine-treated and its homologous FMT treatment.
Conclusions
Our results indicate that under our experimental conditions, fecal transplant can reduce the severity of nicotine withdrawal. This suggests that interactions along the gut-brain axis are important for the development of nicotine dependence and might help lower the risk of cancer and other serious health problems in humans.
Implications
This report shows for the first time that the gut microbiome may modulate nicotine withdrawal intensity in mice. Homologous fecal material transplants (FMT) prevented nicotine-induced gut microbiome dysbiosis and consequently reduced withdrawal severity in mice. These results may have important implications in the management of smoking cessation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond VA 23298, United States.
- Department of Biostatistics, Virginia Commonwealth University, Richmond VA 23298, United States.
- MCCC Bioinformatics Shared Resource Core, Virginia Commonwealth University, Richmond VA 23298, United States.
ORCID-Profile: M Imad Damaj
Förderung
- NCI NIH HHS
- NIDA NIH HHS
- NIH-NCI Cancer Center Support
- NIH
Zitieren
APA
Koseli, E., Tyc, K. M., Buzzi, B., Akbarali, H. I., & Damaj, M. I. (2026). The role of the gut microbiome in nicotine withdrawal and dependence. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntag057
Vancouver
Koseli E, Tyc KM, Buzzi B, Akbarali HI, Damaj MI. The role of the gut microbiome in nicotine withdrawal and dependence. Nicotine & Tobacco Research. 2026. doi:10.1093/ntr/ntag057
BibTeX
@article{Koseli2026,
author = {Koseli, Eda and Tyc, Katarzyna M and Buzzi, Belle and Akbarali, Hamid I and Damaj, M Imad},
title = {The role of the gut microbiome in nicotine withdrawal and dependence},
journal = {Nicotine & Tobacco Research},
year = {2026},
doi = {10.1093/ntr/ntag057}
}
EUVIMED